Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Decreased antigen (Ag)-specific T cell (TC) proliferation and IL-2 production are detected in all stages of HIV disease. To determine whether dendritic cell dysfunction and/or abnormal cytokine production contribute to HIV-induced immune dysregulation, we studies TC responses to recall Ags (influenza virus and tetanus toxoid) presented by Langerhans cells (LC) in six pairs of HIV-discordant identical twins, and the modulation of these responses by anti-IL-10 (alphaIL-10) mAbs and IL-12. LC from HIV+ twins induced IL-2 comparable to normal LC in cultures containing TC from uninfected twins. In contrast, IL-2 production was markedly decreased in cultures containing TC from HIV+ twins. IL-12 enhanced Ag-specific IL-2 production by TC from two patients with CD4+ counts > 600. In contrast, alphaIL-10 mAbs enhanced IL-2 production in influenza virus-stimulated cultures containing TC from two patients with CD4+ counts < 20. Thus, these findings suggest that immunologic dysfunction of dendritic cells does not contribute to impaired secondary immune responses in HIV+ individuals. Although few patients were studied, partial immune reconstitution in vitro, as demonstrated here, may help to predict those individuals who might benefit from cytokines or antibodies against cytokines as immunotherapy for HIV disease.

[1]  I. Frank,et al.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients , 1992, The Journal of experimental medicine.

[2]  G. Trinchieri,et al.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.

[3]  K. Wolff,et al.  Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. , 1992, The Journal of investigative dermatology.

[4]  M. Negroni,et al.  Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. , 1993, Journal of acquired immune deficiency syndromes.

[5]  P. Linsley,et al.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. , 1993, Journal of immunology.

[6]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[7]  D. Weissman,et al.  Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[9]  S. Steinberg,et al.  Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. , 1995, Journal of immunology.

[10]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  H. Schuitemaker,et al.  Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages , 1994, Journal of virology.

[12]  M. Clerici,et al.  Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. , 1990, Clinical immunology and immunopathology.

[13]  J. Berzofsky,et al.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. , 1993, Science.

[14]  S. Patterson,et al.  Suppression of immune responses by dendritic cells infected with HIV. , 1989, Immunology.

[15]  K. Wolff,et al.  Epidermal Langerhans cells--a target for HTLV-III/LAV infection. , 1987, The Journal of investigative dermatology.

[16]  Susanne A. Fischer,et al.  Interleukin‐12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells , 1993, European journal of immunology.

[17]  R. Steinman,et al.  Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 , 1994, Cell.

[18]  M. Lederman,et al.  Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. , 1988, The Journal of laboratory and clinical medicine.

[19]  M. Clerici,et al.  The Th1-Th2 hypothesis of HIV infection: new insights. , 1994, Immunology today.

[20]  S. Beissert,et al.  IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. , 1995, Journal of immunology.

[21]  E. Clark,et al.  The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. , 1994, Immunity.

[22]  A. Pinching,et al.  Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. , 1992, Immunology.

[23]  C. Ballaun,et al.  Epidermal langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. , 1994, The Journal of investigative dermatology.

[24]  J. Nielsen,et al.  Immunological Studies in the Acquired Immunodeficiency Syndrome , 1986, Scandinavian journal of immunology.

[25]  R. Steinman,et al.  During HIV‐1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion , 1992, Clinical and experimental immunology.

[26]  F. Miedema,et al.  Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. , 1994, Blood.

[27]  F. Nestle,et al.  Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. , 1995, Journal of immunology.

[28]  L. Montaner,et al.  Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. , 1994, The Journal of general virology.

[29]  J. Farrant,et al.  Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function. , 1988, Clinical and experimental immunology.

[30]  R. Puri,et al.  IL-10 inhibits HIV-1 replication and is induced by tat. , 1994, Biochemical and biophysical research communications.

[31]  K. Cooper,et al.  Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation. , 1986, The Journal of investigative dermatology.

[32]  J. Berzofsky,et al.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. , 1994, The Journal of clinical investigation.

[33]  A. Enk,et al.  Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. , 1993, Journal of immunology.

[34]  R. Collman,et al.  CD4-independent infection of human peripheral blood dendritic cells with isolates of human immunodeficiency virus type 1. , 1993, The Journal of general virology.

[35]  R. Steinman,et al.  Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. , 1994, The Journal of clinical investigation.

[36]  G. Trinchieri,et al.  Impaired interleukin 12 production in human immunodeficiency virus- infected patients , 1994, The Journal of experimental medicine.

[37]  K Inaba,et al.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. , 1992, Science.

[38]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[39]  M. Helbert,et al.  Antigen presentation, loss of immunological memory and AIDS. , 1993, Immunology today.

[40]  D. Weissman,et al.  Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. , 1996, AIDS research and human retroviruses.

[41]  M. Capobianchi,et al.  Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages , 1995, Journal of virology.

[42]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[43]  S E Macatonia,et al.  HIV I infection of dendritic cells. , 1990, International reviews of immunology.

[44]  A. Giannetti,et al.  Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. , 1994, Journal of acquired immune deficiency syndromes.

[45]  S E Macatonia,et al.  Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. , 1990, Immunology.

[46]  E. Halapi,et al.  CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE , 1995, The Journal of experimental medicine.

[47]  P. Dunbar,et al.  The IL4- induced switch of CD8+ T cells to a TH2 phenotype and its possible relationship to the onset of AIDS. , 1994, Research in immunology.

[48]  A. Fauci,et al.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.

[49]  S. Reed,et al.  IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. , 1994, Journal of immunology.

[50]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[51]  A. Lazzarin,et al.  In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high‐risk HIV‐negative intravenous drug users , 1995, AIDS.